|
ASTE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.49456052773212E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
8.548400E-01 |
| Stage1-vs-Stage3 |
6.869900E-02 |
| Stage1-vs-Stage4 |
2.41959999999208E-05 |
| Stage2-vs-Stage3 |
1.772210E-01 |
| Stage2-vs-Stage4 |
1.896500E-03 |
| Stage3-vs-Stage4 |
2.183600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
5.76090000037333E-07 |
| Normal-vs-Asian |
2.40718556199226E-12 |
| Caucasian-vs-AfricanAmerican |
3.649000E-01 |
| Caucasian-vs-Asian |
3.182200E-01 |
| AfricanAmerican-vs-Asian |
7.214800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.724600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.56342999999559E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.021000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.877800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.179400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.671600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.723400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.386200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.70750000033837E-07 |
| Classical-VS-Follicular |
9.186200E-02 |
| Classical-VS-Other |
5.587600E-01 |
| Classical-VS-Normal |
1.6242562850266E-12 |
| Tall-VS-Follicular |
1.78870000033804E-07 |
| Tall-VS-Other |
2.444800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
3.069000E-01 |
| Follicular-VS-Normal |
5.37014877011188E-12 |
| Other-VS-Normal |
3.57420000000053E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.439000E-04 |
|
|
